Center-Authored Papers

Filters: Author is Hoering, Antje  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
Waldenstrom Macroglobulinemia
Tumor Markers, Biological
Treatment Outcome
Time Factors
Thalidomide
Survival Rate
Survival Analysis
Southwestern United States
Societies, Medical
Risk Factors
Research Design
Hoering A, LeBlanc M, Crowley J.  2008.  Randomized phase III clinical trial designs for targeted agents.. Clinical cancer research : an official journal of the American Association for Cancer Research. 14(14):4358-67. Abstract
Hoering A, LeBlanc M, Crowley J.  2011.  Seamless phase I-II trial design for assessing toxicity and efficacy for targeted agents.. Clinical cancer research : an official journal of the American Association for Cancer Research. 17(4):640-6. Abstract
Remission Induction